Adjuvant therapy for renal cell carcinoma
- 1 May 2008
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 10 (3), 245-252
- https://doi.org/10.1007/s11912-008-0037-4
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Antiangiogenic Potential of the Mammalian Target of Rapamycin Inhibitor TemsirolimusCancer Research, 2006
- Laparoscopic Partial Nephrectomy: 3-Year FollowupJournal of Urology, 2006
- Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic optionsBJU International, 2005
- A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMAJournal of Urology, 2005
- Prognostic Factors in Patients with Advanced Renal Cell CarcinomaClinical Cancer Research, 2004
- Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinomaCancer, 2003
- Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized TrialJournal of Clinical Oncology, 2003
- Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized studyCancer, 1996
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994